Cargando…

Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)

Heat shock protein 90 (Hsp90) is a crucial component in carcinogenesis and serves as a molecular chaperone that facilitates protein maturation whilst protecting cells against temperature-induced stress. The function of Hsp90 is highly dependent on adenosine triphosphate (ATP) binding to the N-termin...

Descripción completa

Detalles Bibliográficos
Autores principales: Magwenyane, Ayanda M., Mhlongo, Ndumiso N., Lawal, Monsurat M., Amoako, Daniel G., Somboro, Anou M., Sosibo, Sphelele C., Shunmugam, Letitia, Khan, Rene B., Kumalo, Hezekiel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221724/
https://www.ncbi.nlm.nih.gov/pubmed/32295059
http://dx.doi.org/10.3390/molecules25081785
_version_ 1783533427079774208
author Magwenyane, Ayanda M.
Mhlongo, Ndumiso N.
Lawal, Monsurat M.
Amoako, Daniel G.
Somboro, Anou M.
Sosibo, Sphelele C.
Shunmugam, Letitia
Khan, Rene B.
Kumalo, Hezekiel M.
author_facet Magwenyane, Ayanda M.
Mhlongo, Ndumiso N.
Lawal, Monsurat M.
Amoako, Daniel G.
Somboro, Anou M.
Sosibo, Sphelele C.
Shunmugam, Letitia
Khan, Rene B.
Kumalo, Hezekiel M.
author_sort Magwenyane, Ayanda M.
collection PubMed
description Heat shock protein 90 (Hsp90) is a crucial component in carcinogenesis and serves as a molecular chaperone that facilitates protein maturation whilst protecting cells against temperature-induced stress. The function of Hsp90 is highly dependent on adenosine triphosphate (ATP) binding to the N-terminal domain of the protein. Thus, inhibition through displacement of ATP by means of competitive binding with a suitable organic molecule is considered an attractive topic in cancer research. Radicicol (RD) and its derivative, resorcinylic isoxazole amine NVP-AUY922 (NVP), have shown promising pharmacodynamics against Hsp90 activity. To date, the underlying binding mechanism of RD and NVP has not yet been investigated. In this study, we provide a comprehensive understanding of the binding mechanism of RD and NVP, from an atomistic perspective. Density functional theory (DFT) calculations enabled the analyses of the compounds’ electronic properties and results obtained proved to be significant in which NVP was predicted to be more favorable with solvation free energy value of −23.3 kcal/mol and highest stability energy of 75.5 kcal/mol for a major atomic delocalization. Molecular dynamic (MD) analysis revealed NVP bound to Hsp90 (NT-NVP) is more stable in comparison to RD (NT-RD). The Hsp90 protein exhibited a greater binding affinity for NT-NVP (−49.4 ± 3.9 kcal/mol) relative to NT-RD (−28.9 ± 4.5 kcal/mol). The key residues influential in this interaction are Gly 97, Asp 93 and Thr 184. These findings provide valuable insights into the Hsp90 dynamics and will serve as a guide for the design of potent novel inhibitors for cancer treatment.
format Online
Article
Text
id pubmed-7221724
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72217242020-05-21 Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922) Magwenyane, Ayanda M. Mhlongo, Ndumiso N. Lawal, Monsurat M. Amoako, Daniel G. Somboro, Anou M. Sosibo, Sphelele C. Shunmugam, Letitia Khan, Rene B. Kumalo, Hezekiel M. Molecules Article Heat shock protein 90 (Hsp90) is a crucial component in carcinogenesis and serves as a molecular chaperone that facilitates protein maturation whilst protecting cells against temperature-induced stress. The function of Hsp90 is highly dependent on adenosine triphosphate (ATP) binding to the N-terminal domain of the protein. Thus, inhibition through displacement of ATP by means of competitive binding with a suitable organic molecule is considered an attractive topic in cancer research. Radicicol (RD) and its derivative, resorcinylic isoxazole amine NVP-AUY922 (NVP), have shown promising pharmacodynamics against Hsp90 activity. To date, the underlying binding mechanism of RD and NVP has not yet been investigated. In this study, we provide a comprehensive understanding of the binding mechanism of RD and NVP, from an atomistic perspective. Density functional theory (DFT) calculations enabled the analyses of the compounds’ electronic properties and results obtained proved to be significant in which NVP was predicted to be more favorable with solvation free energy value of −23.3 kcal/mol and highest stability energy of 75.5 kcal/mol for a major atomic delocalization. Molecular dynamic (MD) analysis revealed NVP bound to Hsp90 (NT-NVP) is more stable in comparison to RD (NT-RD). The Hsp90 protein exhibited a greater binding affinity for NT-NVP (−49.4 ± 3.9 kcal/mol) relative to NT-RD (−28.9 ± 4.5 kcal/mol). The key residues influential in this interaction are Gly 97, Asp 93 and Thr 184. These findings provide valuable insights into the Hsp90 dynamics and will serve as a guide for the design of potent novel inhibitors for cancer treatment. MDPI 2020-04-13 /pmc/articles/PMC7221724/ /pubmed/32295059 http://dx.doi.org/10.3390/molecules25081785 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Magwenyane, Ayanda M.
Mhlongo, Ndumiso N.
Lawal, Monsurat M.
Amoako, Daniel G.
Somboro, Anou M.
Sosibo, Sphelele C.
Shunmugam, Letitia
Khan, Rene B.
Kumalo, Hezekiel M.
Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_full Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_fullStr Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_full_unstemmed Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_short Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)
title_sort understanding the hsp90 n-terminal dynamics: structural and molecular insights into the therapeutic activities of anticancer inhibitors radicicol (rd) and radicicol derivative (nvp-yua922)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221724/
https://www.ncbi.nlm.nih.gov/pubmed/32295059
http://dx.doi.org/10.3390/molecules25081785
work_keys_str_mv AT magwenyaneayandam understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT mhlongondumison understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT lawalmonsuratm understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT amoakodanielg understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT somboroanoum understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT sosibosphelelec understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT shunmugamletitia understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT khanreneb understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922
AT kumalohezekielm understandingthehsp90nterminaldynamicsstructuralandmolecularinsightsintothetherapeuticactivitiesofanticancerinhibitorsradicicolrdandradicicolderivativenvpyua922